İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025 · article

Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells

YÖKSİS OpenAlex Açık erişim · gold Üst %10
Yıl2025
Atıf3OpenAlex
Yüzdelik%94,2
FWCI4,861,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıPharmacology Research & Perspectives
  • Katalog eşleşmesi (ISSN)Pharmacology Research and Perspectives
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

ABSTRACT Lichen secondary metabolites with many remarkable biological activities are used in cancer treatments due to their low side effects and high anticancer potential. In particular, these metabolites constitute an interesting research area in cancer treatments due to their potential to induce apoptosis and suppress metastasis by inhibiting cancer‐related signaling pathways. The Wnt/β‐catenin signaling pathway plays a role in important biological processes such as oncogenesis, cell cycle regulation, cell proliferation, metastasis, differentiation, apoptosis, and drug resistance. Therefore, inhibition of this pathway is a potential target in cancer therapies. There is no detailed study explaining the potential anticancer molecular mechanism of the lichen secondary metabolite lobaric acid (LA) on breast cancer. Here, it is aimed to investigate the effect of LA on viability, apoptosis, and migration in MCF‐7 cells and to elucidate the relationship between the potential anticancer effect and the Wnt/β‐catenin signaling pathway. The dose‐ and time‐dependent viability of LA‐treated MCF‐7 cells was evaluated by XTT assay, and the IC50 value was determined as 44.21 μg/mL at 48 h. LA increased the apoptotic cell population, as shown by flow cytometry analysis, qPCR, and Western blot results. LA inhibited β‐catenin by inducing GSK3‐β protein expression, thereby suppressing Wnt/β‐catenin target genes. LA might be a natural active compound candidate for breast cancer treatment.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

3atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 2 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2026 Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspectiveAtıf 1 · OpenAlex
  2. 2026 Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspectiveAtıf 1 · OpenAlex

Yazarlar

7
  1. Şeydanur Kalın 1
  2. KÜBRA NUR BAYINDIRLI 2
  3. EMİNE TORAMAN 3
  4. ŞÜKRAN GÜNAYDIN 4
  5. Fatmanur Keleş 5
  6. AHMET ALTAY ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ 6
  7. HARUN BUDAK 7